Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international ...

The Lung Cancer Genetics Study aims to identify genetic variations linked to lung cancer, enhancing risk assessments and treatment strategies. Collaboration between 23andMe and lung cancer advocates ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, can cause aggressive disease at a young age.

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Confluence Genetics today announced the launch of Cas-CLEAR™, Collaterally Enhanced Activated Ribonuclease, a new CRISPR technology platform for the treatment of cancers carrying defined genetic ...

Scientists have found that genetics and type of cancer treatment contribute most to a survivor's risk of a second cancer. Physicians caring for survivors of childhood cancer later in life should be ...

Breast cancer is the most common cancer in women worldwide. In sub-Saharan Africa, it is a leading cause of cancer-related deaths among women. Risk factors for developing breast cancer include being ...

Marcy Richardson from Ambry Genetics discusses the importance of a new study that assessed the functional impact of thousands of BRCA2 variants, identifying those that may increase cancer risk. What ...

NewYork-Presbyterian's program offers self-referred genetic testing, focusing on personalized cancer prevention and care.

South African scientists have identified two new breast cancer genes -- RAB27A and USP22 -- in Black women, marking the first GWAS of its kind on the continent. This breakthrough highlights the need ...